In this episode, Laura Enyedi, MD, chats with guest Kathryn Colby, MD, PhD, about her schooling, career, mentorship, chairmanship and being a parent.

• Welcome to another episode of Mend the Gap 1:04
• Introduction 1:14
• Welcome Kathryn Colby, MD, PhD 2:31
• Tell us about where you’re from, where you grew up and how you became an ophthalmologist. 2:47
• In college, did you know you wanted to go to medical school? 4:36
• What was your PhD work on? 5:09
• Enyedi and Colby discuss Colby’s psychiatry background and how it prepared her to being a chairperson and a mother. 6:49
• Colby talks about motherhood while attending medical school. 7:36
• Colby chats about mentorship and model behavior. 8:51
• Enyedi and Colby discuss being effective mentors and mothers. 10:43
• How did you become a chairman? 13:04
• Enyedi and Colby talk about kids, motherhood and careers. 16:51
• Is it different being a chair in one place versus another? 18:47
• Enyedi and Colby chat about making tough decisions. 23:10
• Colby talks about being a fan of opera. 24:31
• What is your favorite book? 26:49
• Women in Ophthalmology 29:56
• Thank you 30:58

We’d love to hear from you! Send your comments/questions to [email protected]. Follow us on Twitter @Healio_OSN.

Laura Enyedi, MD, is professor of ophthalmology and pediatrics at Duke Eye Center and medical director of South Durham Ophthalmology in North Carolina.

Kathryn Colby, MD, PhD, is an internationally renowned academic corneal specialist with a longstanding interest in Fuchs dystrophy. She is currently pioneering novel, non-transplant treatments for this condition and has specific expertise in the management of ocular surface tumors, pediatric corneal disease, infectious keratitis and keratoprosthesis. She is also the Elisabeth J. Cohen professor and chairman of the department of ophthalmology New York University Grossman School of Medicine.

Disclosures: The hosts report no relevant financial disclosures. Colby serves on the executive committee for the Zoster Eye Disease Study, the US chair for a multi-national, multi-center study examining the role of Rho kinase inhibition in corneal endothelial rejuvenation and serves on numerous boards of directors for the Cornea Society.